About Dr Lalchandani Labs
Dr Lalchandani Labs is a publicly listed company based in Delhi (India) founded in 1986 by Arjan Lal Chandani. It offers pathology, radiology, and health checkup services with home collection. It operates on a B2C and B2B model. The company has 14 employees. Its Indian entity Dr Lalchandani Labs Limited reported revenue of ₹4.19 Cr. Dr Lalchandani Labs offers products and services including Health Checkup Packages, Pathology Tests, and Radiology Services. Its focus areas include Diagnostics, Pathology, Blood Testing and Radiology. Its competitors include Thyrocare, Vijaya Diagnostic Centre and Suraksha Diagnostics; 2 of its 3 listed competitors have raised funding.
Company details
Dr Lalchandani Labs is a diagnostic center in New Delhi with over 32 years of experience. It delivers pathology, radiology, and health checkup services, including home sample collection and online reporting. The lab serves individuals and corporates with affordable packages for tests like blood profiles and imaging. It emphasizes quality, reliability, and timely results through accredited facilities.
- Headquarters Delhi, India
- Employees 14
- Founders Arjan Lal Chandani
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lalchandanipathlab.com
- Social X Facebook
- Legal Name Dr. Lalchandani Labs Ltd.
- Market Cap₹6.00 Cr
DLCL · BSE
- Share Price₹6.69
-3.74% today
- Revenue₹4.19 Cr
FY 2025-26 · -5.8% YoY
- EBITDA₹0.69 Cr
Margin 16.5%
- Net Profit₹0.07 Cr
FY 2025-26 · -75.9% YoY
- P/E (TTM)94.5x
P/B 0.4x
- Employee Count14
Associated legal entities of Dr Lalchandani Labs
Dr Lalchandani Labs operates through Dr Lalchandani Labs Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dr Lalchandani Labs Limited Listed CIN L85320DL2017PLC321605 | Active | 02 Aug 2017 | New Delhi, Delhi | ₹4.2 Cr | 14 | 7 | View details |
Products & Services of Dr Lalchandani Labs
Dr Lalchandani Labs offers a comprehensive portfolio of products and services, including Health Checkup Packages, Pathology Tests, and Radiology Services.
Packages for blood tests and health screenings with home collection
Tests like CBC and lipid profiles for health monitoring
Diagnostic imaging for medical evaluations
Board of directors of Dr Lalchandani Labs Limited (Dr Lalchandani Labs)
Dr Lalchandani Labs Limited is the primary company behind Dr Lalchandani Labs. The board of Dr Lalchandani Labs Limited currently have 6 directors; the longest-serving is Mohit Lal Chandani, appointed in 2017. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mohit Lal Chandani DIN 07873508 | Whole-time director | 02 Aug 2017 | 9 yrs 3 mo | Dr Lalchandani Labs Limited |
| Arjan Lal Chandani DIN 07014579 | Managing Director | 02 Aug 2017 | 9 yrs 3 mo | Dr Lalchandani Labs Limited |
| Anchal Gupta DIN 07873466 | Director | 02 Aug 2017 | 9 yrs 3 mo | Dr Lalchandani Labs Limited |
| Rajiv Handa DIN 08036399 | Director | 27 Dec 2017 | 8 yrs 10 mo | Dr Lalchandani Labs Limited |
| Swati Chandra DIN 09514968 | Director | 09 Mar 2022 | 4 yrs 7 mo | Dr Lalchandani Labs Limited |
| Mohan Lal Gandhi DIN 00800786 | Director | 30 Sep 2025 | 1 yr 1 mo | Dr Lalchandani Labs Limited |
People of Dr Lalchandani Labs
1 people are tracked at Dr Lalchandani Labs (1 in leadership); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
| Founder, MD | Leadership |
Complete people profiles for Dr Lalchandani Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Dr Lalchandani Labs
Dr Lalchandani Labs is a publicly listed company on the BSE with ticker symbol DLCL in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date09 May 2018
- Listed onBSE: DLCL
- Listed entityDr. Lalchandani Labs Ltd.
- Exchange sectorHealth services
- ISININE871Z01013
- Share price₹6.90 (-1.43% on the day) · 2026-10-14
- Volume (last session)32,000
Financials of Dr Lalchandani Labs
Exchange-reported figures of Dr Lalchandani Labs Limited, the listed company behind Dr Lalchandani Labs (BSE: DLCL).
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 4.19 | 4.45 | 4.81 | 5.04 | 11.28 | 9.78 | 6.10 |
| Revenue growth | -5.8% | -7.5% | -4.6% | -55.3% | +15.3% | +60.3% | - |
| EBITDA | 0.69 | 0.92 | 0.19 | 0.09 | 2.46 | 2.24 | 1.26 |
| EBITDA margin | +16.5% | +20.7% | +4.0% | +1.8% | +21.8% | +22.9% | +20.7% |
| Profit before tax | 0.10 | 0.40 | 0.62 | (1.56) | 1.27 | 1.37 | 0.66 |
| Net profit | 0.07 | 0.29 | (0.76) | (1.56) | 0.91 | 1.01 | 0.47 |
| Net profit margin | +1.7% | +6.5% | -15.8% | -31.0% | +8.1% | +10.3% | +7.7% |
| EPS (₹) | 0.07 | 0.96 | 1.43 | (3.61) | 2.15 | 2.33 | 1.09 |
| Balance sheet | |||||||
| Total assets | - | 14.02 | 13.02 | 15.33 | 15.63 | 13.59 | 10.30 |
| Net worth | - | 9.95 | 9.54 | 8.92 | 10.48 | 9.55 | 8.54 |
| Total debt | - | 4.07 | 3.48 | 6.40 | 5.15 | 4.04 | 1.76 |
| Cash & bank | - | 3.30 | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 |
| Net working capital | - | 9.27 | 7.67 | 8.79 | 8.47 | 7.09 | 6.00 |
| Cash flow | |||||||
| Cash from operations | - | 0.37 | (0.22) | 0.00 | 2.01 | 1.19 | (0.10) |
| Cash from investing | - | 0.06 | 1.00 | (0.20) | (1.53) | (2.26) | (0.53) |
| Cash from financing | - | 0.58 | (1.59) | (0.23) | 0.16 | 1.71 | 0.85 |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.19 | 4.45 | 4.81 | 5.04 | 11.28 | 9.78 | 6.10 |
| Revenue growth | -5.8% | -7.5% | -4.6% | -55.3% | +15.3% | +60.3% | - |
| Other income | 0.00 | 0.13 | 1.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 3.50 | 3.53 | 4.62 | 4.95 | 8.82 | 7.54 | 4.84 |
| Employee cost | 0.00 | 0.48 | 0.72 | 1.11 | 1.11 | 0.42 | 0.57 |
| EBITDA | 0.69 | 0.92 | 0.19 | 0.09 | 2.46 | 2.24 | 1.26 |
| EBITDA margin | +16.5% | +20.7% | +4.0% | +1.8% | +21.8% | +22.9% | +20.7% |
| Depreciation | 0.57 | 0.56 | 0.62 | 0.66 | 0.59 | 0.52 | 0.42 |
| Interest | 0.02 | 0.09 | 0.38 | 0.99 | 0.60 | 0.35 | 0.18 |
| Profit before tax | 0.10 | 0.40 | 0.62 | (1.56) | 1.27 | 1.37 | 0.66 |
| Tax | 0.03 | (0.01) | 0.00 | 0.00 | 0.36 | 0.36 | 0.19 |
| Net profit | 0.07 | 0.29 | (0.76) | (1.56) | 0.91 | 1.01 | 0.47 |
| Net profit margin | +1.7% | +6.5% | -15.8% | -31.0% | +8.1% | +10.3% | +7.7% |
| EPS (₹) | 0.07 | 0.96 | 1.43 | (3.61) | 2.15 | 2.33 | 1.09 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 |
| Reserves & surplus | - | 5.62 | 5.21 | 4.59 | 6.15 | 5.22 | 4.21 |
| Shareholders' funds (net worth) | - | 9.95 | 9.54 | 8.92 | 10.48 | 9.55 | 8.54 |
| Secured loans | - | 0.00 | 0.00 | 1.21 | 1.43 | 1.62 | 0.97 |
| Unsecured loans | - | 4.07 | 3.48 | 5.19 | 3.72 | 2.42 | 0.79 |
| Total debt | - | 4.07 | 3.48 | 6.40 | 5.15 | 4.04 | 1.76 |
| Total liabilities | - | 14.02 | 13.02 | 15.33 | 15.63 | 13.59 | 10.30 |
| Assets | |||||||
| Gross block | - | 7.35 | 7.27 | 8.05 | 7.74 | 6.65 | 4.35 |
| Net block | - | 3.51 | 3.99 | 5.40 | 5.75 | 5.25 | 3.47 |
| Capital work in progress | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | - | 0.27 | 0.41 | 0.24 | 0.24 | 0.24 | 0.24 |
| Inventories | - | 1.29 | 1.44 | 1.52 | 1.56 | 0.68 | 0.50 |
| Sundry debtors | - | 5.26 | 4.70 | 4.97 | 4.22 | 3.98 | 3.33 |
| Cash & bank balances | - | 3.30 | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 |
| Loans & advances | - | 1.02 | 1.05 | 1.43 | 1.50 | 1.01 | 1.48 |
| Total current assets | - | 10.87 | 9.48 | 11.02 | 10.81 | 8.56 | 7.56 |
| Total current liabilities | - | 1.60 | 1.81 | 2.23 | 2.34 | 1.47 | 1.56 |
| Net working capital | - | 9.27 | 7.67 | 8.79 | 8.47 | 7.09 | 6.00 |
| Total assets | - | 14.02 | 13.02 | 15.33 | 15.63 | 13.59 | 10.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 | 2.02 |
| Net cash from operating activities | - | 0.37 | (0.22) | 0.00 | 2.01 | 1.19 | (0.10) |
| Net cash from investing activities | - | 0.06 | 1.00 | (0.20) | (1.53) | (2.26) | (0.53) |
| Net cash from financing activities | - | 0.58 | (1.59) | (0.23) | 0.16 | 1.71 | 0.85 |
| Net change in cash | - | 1.01 | (0.81) | (0.43) | 0.64 | 0.64 | 0.23 |
| Closing cash | - | 3.30 | 2.29 | 3.10 | 3.53 | 2.89 | 2.25 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -5.8% | -7.5% | -4.6% | -55.3% | +15.3% | +60.3% | - |
| EBITDA growth | -25.0% | +384.2% | +111.1% | -96.3% | +9.8% | +77.8% | - |
| PBT growth | -75.0% | -35.5% | +9998.0% | - | -7.3% | +107.6% | -8.3% |
| Net income growth | -75.9% | +138.2% | +51.3% | -271.4% | -9.9% | +114.9% | - |
| Revenue CAGR (3Y) | -6.0% | -26.7% | -21.1% | -6.2% | +29.0% | +51.9% | +44.3% |
| EBITDA CAGR (3Y) | +97.2% | -28.0% | -56.1% | -58.5% | +27.0% | +52.6% | +33.5% |
| Profitability & leverage | |||||||
| Net income margin | +1.7% | +9.2% | +12.9% | -31.0% | +8.1% | +10.3% | +7.7% |
| Return on capital employed | - | +2.7% | -2.7% | -3.7% | +12.9% | +14.5% | +8.7% |
| Return on net worth | - | +3.1% | -8.2% | -16.1% | +9.3% | +11.2% | +5.7% |
| Debt / equity | - | 0.39 | 0.54 | 0.60 | 0.46 | 0.32 | 0.16 |
| Long-term debt / equity | - | 0.01 | 0.19 | 0.31 | 0.26 | 0.23 | 0.12 |
| Interest cover | 16.67 | 25.00 | -88.37 | -173.68 | 32.09 | 20.35 | 21.43 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.61 | 0.63 | 0.64 | 1.57 | 1.78 | 1.51 |
| Inventory turnover | - | 3.26 | 3.25 | 3.27 | 10.07 | 16.58 | 13.71 |
| Debtors turnover | - | 0.89 | 0.99 | 1.10 | 2.75 | 2.68 | 2.36 |
| EPS (₹) | 0.07 | 0.96 | 1.43 | (3.61) | 2.15 | 2.33 | 1.09 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 22.98 | 22.02 | 20.59 | 24.16 | 22.01 | 19.68 |
Competitors of Dr Lalchandani Labs
Dr Lalchandani Labs has 3 listed competitors in our database, 2 of them funded. They include Thyrocare, Vijaya Diagnostic Centre and Suraksha Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| thyrocare.com | 1996 | Mumbai, India | $63.59M | 1,889 | Diagnostic testing centers for pathology and health screenings are operated. | |
| vijayadiagnostic.com | 1981 | Hyderabad, India | Diagnostic services are offered via a chain of centers. | |||
| surakshanet.com | 2005 | Kolkata, India | $49M | 1,180 | Pathology, molecular diagnostics, and imaging services are provided. |
Detailed competitors of Dr Lalchandani Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dr Lalchandani Labs
The website of Dr Lalchandani Labs (lalchandanipathlab.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 1.1% vs previous month
Websites whose visitors overlap most with Dr Lalchandani Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| drdangslab.com | 100% | 15.7K | #1,272,375 | View details | |
instpath.gov.in | instpath.gov.in | 97% | #6,783,409 | – | |
| lotusdiagnostic.com | 96% | #989,167 | View details | ||
| luciddiagnostics.com | 94% | 43.9K | #618,113 | View details | |
| andersondiagnostics.com | 94% | 34.3K | #799,169 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for Dr Lalchandani Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dr Lalchandani Labs
Complete news archive for Dr Lalchandani Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dr Lalchandani Labs
Dr Lalchandani Labs was founded in 1986.
Dr Lalchandani Labs is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Dr Lalchandani Labs has 14 employees.
The primary company behind Dr Lalchandani Labs, Dr Lalchandani Labs Limited, reported revenue of ₹4.19 Cr for FY 2026, down 6% year on year.
Dr Lalchandani Labs is a diagnostic center in New Delhi with over 32 years of experience. It delivers pathology, radiology, and health checkup services, including home sample collection and online reporting. The lab serves individuals and corporates with affordable packages for tests like blood profiles and imaging. It emphasizes quality, reliability, and timely results through accredited facilities.
Dr Lalchandani Labs's top competitors include Thyrocare, Suraksha Diagnostics and Vijaya Diagnostic Centre.
Dr Lalchandani Labs offers Health Checkup Packages, Pathology Tests, and Radiology Services.
Yes, Dr Lalchandani Labs is publicly traded on BSE under the ticker symbol DLCL.
Dr Lalchandani Labs operates through Dr Lalchandani Labs Limited.
The legal entities of Dr Lalchandani Labs currently have 6 directors, including Mohit Lal Chandani, Arjan Lal Chandani, Anchal Gupta and others.